AustralianTherapeutic Goods Administration (TGA) Australian

Australia’s TGA Clears ResApp Health’s Wearable Cough Monitor

March 30, 2021

ResApp Health has received clearance from Australia’s Therapeutic Goods Administration (TGA) for its wearable cough-monitoring system.

The clip-on device provides 24/7 monitoring of a patient using an algorithm to analyze cough sounds. It identifies more than 93 percent of cough events and has a false-positive rate of less than 1 percent.

Brisbane-based ResApp said it plans to explore the device’s capabilities and first intends to put the device through clinical trials to evaluate its ability to measure cough frequency.

View today's stories